A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

NCT03258320 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Patients

Interventions

DRUG: Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]